|
1
|
Smith RA, Manassaram-Baptiste D, Brooks D,
Doroshenk M, Fedewa S, Saslow D, Brawley OW and Wender R: Cancer
screening in the United States, 2015: A review of current American
cancer society guidelines and current issues in cancer screening.
CA Cancer J Clin. 65:30–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thomas A, Liu SV, Subramaniam DS and
Giaccone G: Refining the treatment of NSCLC according to
histological and molecular subtypes. Nat Rev Clin Oncol.
12:511–526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Meerbeeck JP, Fennell DA and De
Ruysscher DK: Small-cell lung cancer. Lancet. 378:1741–1755. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu Y, Lemon W, Liu PY, Yi Y, Morrison C,
Yang P, Sun Z, Szoke J, Gerald WL, Watson M, et al: A gene
expression signature predicts survival of patients with stage I
non-small cell lung cancer. PLoS Med. 3:e4672006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen F, Xiang CX, Zhou Y, Ao XS, Zhou DQ,
Peng P, Zhang HQ, Liu HD and Huang X: Gene expression profile for
predicting survival of patients with meningioma. Int J Oncol.
46:791–797. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu Z, Zhou Y, Cao Y, Dinh TL, Wan J and
Zhao M: Identification of candidate biomarkers and analysis of
prognostic values in ovarian cancer by integrated bioinformatics
analysis. Med Oncol. 33:1302016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ioannidis JP, Allison DB, Ball CA,
Coulibaly I, Cui X, Culhane AC, Falchi M, Furlanello C, Game L,
Jurman G, et al: Repeatability of published microarray gene
expression analyses. Nat Genet. 41:149–155. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu TP, Tsai MH, Lee JM, Hsu CP, Chen PC,
Lin CW, Shih JY, Yang PC, Hsiao CK, Lai LC and Chuang EY:
Identification of a novel biomarker, SEMA5A, for non-small cell
lung carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers
Prev. 19:2590–2597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Landi MT, Dracheva T, Rotunno M, Figueroa
JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, et
al: Gene expression signature of cigarette smoking and its role in
lung adenocarcinoma development and survival. PLoS One.
3:e16512008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:(Database Issue).
D991–D995. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucl Acids Res.
43:(Database Issue). D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun B, Gao L, Ahsan A, Chu P, Song Y, Li
H, Zhang Z, Lin Y, Peng J, Song Z, et al: Anticancer effect of
SZC015 on lung cancer cells through ROS-dependent apoptosis and
autophagy induction mechanisms in vitro. Int Immunopharmacol.
40:400–409. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Győrffy B, Surowiak P, Budczies J and
Lanczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi YX, Zhu T, Zou T, Zhuo W, Chen YX,
Huang MS, Zheng W, Wang CJ, Li X, Mao XY, et al: Prognostic and
predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.
Oncotarget. 7:85235–85243. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gong Y, Yao E, Shen R, Goel A, Arcila M,
Teruya-Feldstein J, Zakowski MF, Frankel S, Peifer M, Thomas RK, et
al: High expression levels of total IGF-1R and sensitivity of NSCLC
cells in vitro to an anti-IGF-1R antibody (R1507). PLoS One.
4:e72732009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dominguez-Brauer C, Thu KL, Mason JM,
Blaser H, Bray MR and Mak TW: Targeting mitosis in cancer: Emerging
strategies. Mol Cell. 60:524–536. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hydbring P, Malumbres M and Sicinski P:
Non-canonical functions of cell cycle cyclins and cyclin-dependent
kinases. Nat Rev Mol Cell Biol. 17:280–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qian X, Song X, He Y, Yang Z, Sun T, Wang
J, Zhu G, Xing W and You C: CCNB2 overexpression is a poor
prognostic biomarker in Chinese NSCLC patients. Biomed
Pharmacother. 74:222–227. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Frescas D and Pagano M: Deregulated
proteolysis by the F-box proteins SKP2 and beta-TrCP: Tipping the
scales of cancer. Nat Rev Cancer. 8:438–449. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Varis A, Salmela AL and Kallio MJ: Cenp-F
(mitosin) is more than a mitotic marker. Chromosoma. 115:288–295.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wordeman L: Microtubule-depolymerizing
kinesins. Curr Opin Cell Biol. 17:82–88. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Taylor SS and McKeon F: Kinetochore
localization of murine Bub1 is required for normal mitotic timing
and checkpoint response to spindle damage. Cell. 89:727–735. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Seo Woo D, You Yeop S, Chung WJ, Cho DH,
Kim JS and Oh Su J: Zwint-1 is required for spindle assembly
checkpoint function and kinetochore-microtubule attachment during
oocyte meiosis. Sci Rep. 5:154312015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kato T, Daigo Y, Aragaki M, Ishikawa K,
Sato M and Kaji M: Overexpression of CDC20 predicts poor prognosis
in primary non-small cell lung cancer patients. J Surg Oncol.
106:423–430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Malumbres M: Therapeutic opportunities to
control tumor cell cycles Clin Transl Oncol. 8:399–408.
2006.PubMed/NCBI
|
